AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Cathie Wood on the Bitcoin Halving, Apple/Open AI & NVDIAs Dominance w/ Cathie Wood | EP #108
Moonshots with Peter Diamandis
Focus on Safety First, Efficacy Follows in CRISPR Therapeutics
2min Snip
00:00
Summary
Transcript
Episode notes
CRISPR Therapeutics prioritized safety over efficacy in their therapies for beta thalassemia and sickle cell disease, as emphasized by Jennifer Doudna. The successful approval of these therapies in the US, UK, and Europe demonstrates their effective approach. Despite the significant advancements in curing diseases, the market remains focused on short-term concerns and fails to recognize the vast potential of gene-editing technologies. The pharmaceutical industry faces challenges due to the emphasis on revenues over innovative potential.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode